Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Cancer survivors can be affected by a number of health problems, but often a major concern is facing cancer again. If the same kind of cancer comes back after treatment it's called a recurrence . But some cancer survivors might develop another type of cancer later (usually more than 10 years after treatment). This is called a second cancer.
People who have had Hodgkin lymphoma (HL) can get any type of second cancer, but research has found they have an increased risk of certain cancers. These tend to be linked to the treatments used for HL. Chemo is linked to blood cancers, and radiation therapy is linked to cancers in the organs in the area that was treated. The cancers include:
The increased risk of many of these cancers are linked to treatment with radiation. For example:
But over time, the use of radiation to treat HL has changed a lot. Radiation is now given in lower doses, and often only to the areas directly affected by the lymphoma. The risks with modern radiation treatment are likely to be lower, still long-term studies are needed to be sure.
Chemotherapy (chemo), especially with drugs called alkylating agents (such as dacarbazine and cyclophosphamide) has been linked with a higher risk of several types of cancer, including leukemias. Today, alkylating agents are used less often and at much lower doses, so these risks are probably not as high as they were in the past, but, again, long-term follow-up studies are needed to be sure.
After completing treatment for HL, you should still see your doctor regularly and may have tests to look for signs that the cancer has come back. Let them know about any new symptoms or problems, because they could be caused by the lymphoma coming back, by a new disease, or by second cancer.
Women who were treated with radiation therapy to the chest (such as mantle field radiation therapy ) before age 30 have an increased risk of breast cancer. The American Cancer Society recommends yearly breast cancer screening with breast MRIs along with mammograms and clinical breast exams beginning at age 30 for these women. Some experts recommend that screening start 8 to 10 years after treatment or at age 40 (whichever is earlier).
The Children’s Oncology Group has guidelines for the follow-up of patients treated for cancer as a child, teen, or young adult, including screening for second cancers. These can be found at www.survivorshipguidelines.org.
Survivors of HL should also follow the American Cancer Society guidelines for the early detection of cancer, such as those for colorectal and lung cancer. Most experts don’t recommend any other testing to look for second cancers unless you have symptoms.
There are steps you can take to help lower your risk and stay as healthy as possible. For example, it’s important to stay away from tobacco products. Smoking increases the risk of many cancers, including some of the second cancers seen in people who have had Hodgkin lymphoma.
To help maintain good health, HL survivors should also:
These steps may also lower the risk of other health problems, including heart disease.
See Second Cancers in Adults for more information.
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers. 2014. Accessed at www.survivorshipguidelines.org on March 22, 2018.
Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin’s disease: A population-based evaluation over 25 years. J Clin Oncol. 2002;20:3484-3494.
Hemminki K, Lenner P, Sundquist J, Bermejo JL. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis. J Clin Oncol. 2008;26:1850-1857.
National Cancer Institute. Childhood Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version. December 1, 2017. Accessed at www.cancer.gov/types/lymphoma/hp/child-hodgkin-treatment-pdq on March 22, 2018.
National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Hodgkin Lymphoma, Version I.2018 -- December 20, 2017. Accessed at www.nccn.org/professionals/physician_gls/pdf/hodgkins.pdf on March 22, 2018.
Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA: A Cancer Journal for Clinicians. 2020;70(4). doi:10.3322/caac.21591. Accessed at https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21591 on June 9, 2020.
Shanbhag S, Ambinder RF. Hodgkin lymphoma: A review and update on recent progress. CA Cancer J Clin. 2018;68(2):116-132.
Last Revised: June 9, 2020